Having opened its office in 2006, PPD is one of the largest contract research organizations (CROs) in Romania today. PPD provides clients with local expertise and efficiency in running trials, leading to shortened development timelines and lowered costs.
With a population of 22 million, Romania provides clients access to a potential patient pool that covers all major therapeutic areas. In addition, a well-defined regulatory process for study startup leads to financial advantages that offset the escalating costs of clinical research. Many new European Union (EU) countries, such as Romania, are experiencing higher costs than before due to improving living standards.
Learn about the benefits and challenges of conducting clinical trials in Central and Eastern Europe. Download our white paper.